-
1
-
-
84891766183
-
Role of chemokines and their receptors in chronic lymphocytic leukemia: Function in microenvironment and targeted therapy
-
Han TT, Fan L, Li JY and Xu W: Role of chemokines and their receptors in chronic lymphocytic leukemia: function in microenvironment and targeted therapy. Cancer Biol Ther 15: 3-9, 2014.
-
(2014)
Cancer Biol Ther
, vol.15
, pp. 3-9
-
-
Han, T.T.1
Fan, L.2
Li, J.Y.3
Xu, W.4
-
2
-
-
77951490243
-
Chemokines and hepatocellular carcinoma
-
Huang F and Geng XP: Chemokines and hepatocellular carcinoma. World J Gastroenterol 16: 1832-1836, 2010.
-
(2010)
World J Gastroenterol
, vol.16
, pp. 1832-1836
-
-
Huang, F.1
Geng, X.P.2
-
3
-
-
0035856010
-
Chemokines and the molecular basis of cancer metastasis
-
Murphy PM: Chemokines and the molecular basis of cancer metastasis. N Engl J Med 345: 833-835, 2001.
-
(2001)
N Engl J Med
, vol.345
, pp. 833-835
-
-
Murphy, P.M.1
-
4
-
-
84867563621
-
Importance of chemokine (CC-motif) ligand 2 in breast cancer
-
Steiner JL and Murphy EA: Importance of chemokine (CC-motif) ligand 2 in breast cancer. Int J Biol Markers 27: e179-e185, 2012.
-
(2012)
Int J Biol Markers
, vol.27
, pp. e179-e185
-
-
Steiner, J.L.1
Murphy, E.A.2
-
5
-
-
84879696455
-
Impact of CCL2 and its receptor CCR2 gene polymorphism in North Indian population: A comparative study in different ethnic groups worldwide
-
Singh V, Srivastava N, Srivastava P and Mittal RD: Impact of CCL2 and Its Receptor CCR2 Gene Polymorphism in North Indian Population: A Comparative Study in Different Ethnic Groups Worldwide. Indian J Clin Biochem 28: 259-264, 2013.
-
(2013)
Indian J Clin Biochem
, vol.28
, pp. 259-264
-
-
Singh, V.1
Srivastava, N.2
Srivastava, P.3
Mittal, R.D.4
-
7
-
-
34247887505
-
Osteosarcoma (osteogenic sarcoma)
-
Picci P: Osteosarcoma (osteogenic sarcoma). Orphanet J Rare Dis 2: 6, 2007.
-
(2007)
Orphanet J Rare Dis
, vol.2
, pp. 6
-
-
Picci, P.1
-
8
-
-
0036467661
-
Prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols
-
Bielack SS, Kempf-Bielack B, Delling G, et al: Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 20: 776-790, 2002.
-
(2002)
J Clin Oncol
, vol.20
, pp. 776-790
-
-
Bielack, S.S.1
Kempf-Bielack, B.2
Delling, G.3
-
9
-
-
77949329326
-
Chemokines and chemokine receptors: New insights into cancer-related inflammation
-
Lazennec G and Richmond A: Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol Med 16: 133-144, 2010.
-
(2010)
Trends Mol Med
, vol.16
, pp. 133-144
-
-
Lazennec, G.1
Richmond, A.2
-
10
-
-
84867334577
-
Cancer-associated fibroblasts up-regulate CCL2, CCL26, IL6 and LOXL2 genes related to promotion of cancer progression in hepatocellular carcinoma cells
-
Lin ZY, Chuang YH and Chuang WL: Cancer-associated fibroblasts up-regulate CCL2, CCL26, IL6 and LOXL2 genes related to promotion of cancer progression in hepatocellular carcinoma cells. Biomed Pharmacother 66: 525-529, 2012.
-
(2012)
Biomed Pharmacother
, vol.66
, pp. 525-529
-
-
Lin, Z.Y.1
Chuang, Y.H.2
Chuang, W.L.3
-
11
-
-
84867771909
-
CCL2/CCR2 chemokine signaling coordinates survival and motility of breast cancer cells through Smad3 protein-and p42/44 mitogen-activated protein kinase (MAPK)-dependent mechanisms
-
Fang WB, Jokar I, Zou A, Lambert D, Dendukuri P and Cheng N: CCL2/CCR2 chemokine signaling coordinates survival and motility of breast cancer cells through Smad3 protein-and p42/44 mitogen-activated protein kinase (MAPK)-dependent mechanisms. J Biol Chem 287: 36593-36608, 2012.
-
(2012)
J Biol Chem
, vol.287
, pp. 36593-36608
-
-
Fang, W.B.1
Jokar, I.2
Zou, A.3
Lambert, D.4
Dendukuri, P.5
Cheng, N.6
-
12
-
-
84876460178
-
CCL2 is critical for immunosuppression to promote cancer metastasis
-
Kudo-Saito C, Shirako H, Ohike M, Tsukamoto N and Kawakami Y: CCL2 is critical for immunosuppression to promote cancer metastasis. Clin Exp Metastasis 30: 393-405, 2013.
-
(2013)
Clin Exp Metastasis
, vol.30
, pp. 393-405
-
-
Kudo-Saito, C.1
Shirako, H.2
Ohike, M.3
Tsukamoto, N.4
Kawakami, Y.5
-
13
-
-
79960411324
-
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
-
Qian BZ, Li J, Zhang H, et al: CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475: 222-225, 2011.
-
(2011)
Nature
, vol.475
, pp. 222-225
-
-
Qian, B.Z.1
Li, J.2
Zhang, H.3
-
14
-
-
77951631347
-
Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth
-
Zhang J, Lu Y and Pienta KJ: Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth. J Natl Cancer Inst 102: 522-528, 2010.
-
(2010)
J Natl Cancer Inst
, vol.102
, pp. 522-528
-
-
Zhang, J.1
Lu, Y.2
Pienta, K.J.3
-
15
-
-
84891960758
-
Chemokines in tumor progression and metastasis
-
Sarvaiya PJ, Guo D, Ulasov I, Gabikian P and Lesniak MS: Chemokines in tumor progression and metastasis. Oncotarget 4: 2171-2185, 2013.
-
(2013)
Oncotarget
, vol.4
, pp. 2171-2185
-
-
Sarvaiya, P.J.1
Guo, D.2
Ulasov, I.3
Gabikian, P.4
Lesniak, M.S.5
-
16
-
-
84862313021
-
Autocrine CCL2 promotes cell migration and invasion via PKC activation and tyrosine phosphorylation of paxillin in bladder cancer cells
-
Chiu HY, Sun KH, Chen SY, et al: Autocrine CCL2 promotes cell migration and invasion via PKC activation and tyrosine phosphorylation of paxillin in bladder cancer cells. Cytokine 59: 423-432, 2012.
-
(2012)
Cytokine
, vol.59
, pp. 423-432
-
-
Chiu, H.Y.1
Sun, K.H.2
Chen, S.Y.3
-
17
-
-
77549086214
-
CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis
-
Zhang J, Patel L and Pienta KJ: CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis. Cytokine Growth Factor Rev 21: 41-48, 2010.
-
(2010)
Cytokine Growth Factor Rev
, vol.21
, pp. 41-48
-
-
Zhang, J.1
Patel, L.2
Pienta, K.J.3
-
18
-
-
53549127988
-
CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulation
-
Roca H, Varsos Z and Pienta KJ: CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulation. J Biol Chem 283: 25057-25073, 2008.
-
(2008)
J Biol Chem
, vol.283
, pp. 25057-25073
-
-
Roca, H.1
Varsos, Z.2
Pienta, K.J.3
-
19
-
-
17144395975
-
The activation of Akt/PKB signaling pathway and cell survival
-
Song G, Ouyang G and Bao S: The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 9: 59-71, 2005.
-
(2005)
J Cell Mol Med
, vol.9
, pp. 59-71
-
-
Song, G.1
Ouyang, G.2
Bao, S.3
-
20
-
-
84897026568
-
Does postoperative infection after soft tissue sarcoma resection affect oncologic outcomes?
-
Behnke NK, Alamanda VK, Song Y, et al: Does postoperative infection after soft tissue sarcoma resection affect oncologic outcomes? J Surg Oncol 109, 415-420, 2014.
-
(2014)
J Surg Oncol
, vol.109
, pp. 415-420
-
-
Behnke, N.K.1
Alamanda, V.K.2
Song, Y.3
-
21
-
-
40149105104
-
A complex pattern of chemokine receptor expression is seen in osteosarcoma
-
von Luettichau I, Segerer S, Wechselberger A, et al: A complex pattern of chemokine receptor expression is seen in osteosarcoma. BMC Cancer 8: 23, 2008.
-
(2008)
BMC Cancer
, vol.8
, pp. 23
-
-
Von Luettichau, I.1
Segerer, S.2
Wechselberger, A.3
-
22
-
-
33748375788
-
Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion
-
Lu Y, Cai Z, Galson DL, et al: Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion. Prostate 66: 1311-1318, 2006.
-
(2006)
Prostate
, vol.66
, pp. 1311-1318
-
-
Lu, Y.1
Cai, Z.2
Galson, D.L.3
-
23
-
-
1642377561
-
ONCOMINE: A cancer microarray database and integrated data-mining platform
-
Rhodes DR, Yu J, Shanker K, et al: ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6: 1-6, 2004.
-
(2004)
Neoplasia
, vol.6
, pp. 1-6
-
-
Rhodes, D.R.1
Yu, J.2
Shanker, K.3
-
24
-
-
84893054197
-
HER2 expression and PI3K-Akt pathway alterations in gastric cancer
-
Sukawa Y, Yamamoto H, Nosho K, et al: HER2 expression and PI3K-Akt pathway alterations in gastric cancer. Digestion 89: 12-17, 2014.
-
(2014)
Digestion
, vol.89
, pp. 12-17
-
-
Sukawa, Y.1
Yamamoto, H.2
Nosho, K.3
-
25
-
-
84894497567
-
Addition of the Akt inhibitor triciribine overcomes antibody resistance in cells from ErbB2/Neu-positive/PTEN-deficient mammary tumors
-
Wang Q, Ding H, Liu B, et al: Addition of the Akt inhibitor triciribine overcomes antibody resistance in cells from ErbB2/Neu-positive/PTEN-deficient mammary tumors. Int J Oncol 44: 1277-1283, 2014.
-
(2014)
Int J Oncol
, vol.44
, pp. 1277-1283
-
-
Wang, Q.1
Ding, H.2
Liu, B.3
-
26
-
-
84892568517
-
Kinome and mRNA expression profiling of high-grade osteosarcoma cell lines implies Akt signaling as possible target for therapy
-
Kuijjer ML, van den Akker BE, Hilhorst R, et al: Kinome and mRNA expression profiling of high-grade osteosarcoma cell lines implies Akt signaling as possible target for therapy. BMC Med Genomics 7: 4, 2014.
-
(2014)
BMC Med Genomics
, vol.7
, pp. 4
-
-
Kuijjer, M.L.1
Van Den Akker, B.E.2
Hilhorst, R.3
-
27
-
-
84879085632
-
Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer
-
Pienta KJ, Machiels JP, Schrijvers D, et al: Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer. Invest New Drugs 31: 760-768, 2013
-
(2013)
Invest New Drugs
, vol.31
, pp. 760-768
-
-
Pienta, K.J.1
Machiels, J.P.2
Schrijvers, D.3
|